Systolic Blood Pressure Went Down 7.4 to 10.6 mmHg in People on Zepbound In the original study, participants who were overweight or obese (meaning they had a body mass index of 27 or greater) taking once-weekly tirzepatide injections of 5 milligrams (mg), 10 mg, or 15 mg for 72 weeks led to average weight reductions of 15 percent, 19.5 percent and 20.9 percent, respectively, compared with placebo
Clinical studies show strong outcomes with both approaches when used consistently alongside diet and lifestyle support, with similar gastrointestinal side effects such as nausea or mild stomach discomfort
JAMA 303 , 14101418 (2010)
Accurate data is essential for various aspects of healthcare, including research, policy-making, and clinical practice
Alpha-lipoic acid alleviates oxidative stress and brain damage in patients with sevoflurane anesthesia